Exclusive: Danaher’s venture arm backs cell therapy manufacturing startup co-founded by Carl June

Danaher Ventures, the venture arm of the life sciences giant Danaher, is investing $18 million into a startup co-founded by Carl June that aims to make cheaper, faster cell therapies.

Novalis LifeSciences and Marshall Wace also participated in the seed round for BlueWhale Bio, which comes out of the University of Pennsylvania.

June, whose research led to the development of CAR-T cell therapy to treat cancer, and Penn professor James Riley are co-inventors of the technology that is the basis of BlueWhale’s platform. June is also a member of Danaher’s scientific advisory board.

Preview

来源: EndPoints

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP

LOG IN

BECOME A PREMIUM SUBSCRIBER

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。